The worldwide proteomics industry is currently experiencing considerable expansion, driven by increasing demand for customized medicine and a broader understanding of disease mechanisms. Recent trends point towards a move toward automated proteomics workflows, particularly driven by advancements in mass spectrometry technology. Furthermore, the exp